Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1908164

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1908164

Neuromodulation Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Neuromodulation Devices Market Summary

The global neuromodulation devices market size was estimated at USD 6.37 billion in 2025 and is projected to reach USD 13.93 billion by 2033, growing at a CAGR of 10.35% from 2026 to 2033. The rising government funding for R&D activities in these devices, increasing prevalence of neurological disorders and technological advancements in these devices are driving the market growth.

For instance, according to the Parkinson's Foundation, around 1 million people are living with Parkinson's disease in the U.S., which is further expected to increase to 1.2 million by 2030. The incidence of neurological disorders is on the rise, leading to an increased need for innovative treatment solutions, including neuromodulation devices. For instance, according to the World Health Organization (WHO) in February 2024, around 5 million people are diagnosed with epilepsy, which is around 49 people per 100,000 population. Moreover, conditions such as Parkinson's disease, essential tremor, dystonia, and medically refractory epilepsy are increasingly being addressed through techniques such as Deep Brain Stimulation (DBS) and other implantable neurostimulation systems. Thus, the increasing prevalence of these conditions significantly increases the demand for advanced neuromodulation devices.

Technological advancements, particularly the continuous introduction of next-generation internal neuromodulation devices, are a major driving force behind the growth of the neuromodulation devices market. Innovations such as miniaturized implantable systems, closed-loop stimulation, AI-driven programming, and wireless or rechargeable platforms are significantly improving device precision, patient comfort, and long-term therapy outcomes. New product launches also expand clinical indications, enabling treatment of chronic pain, movement disorders, epilepsy, depression, and emerging neuropsychiatric conditions with greater efficacy. As companies introduce devices with longer battery life, personalized stimulation algorithms, and enhanced connectivity for remote monitoring, both clinicians and patients are adopting these solutions at a faster pace, supporting broader market expansion and accelerating the global shift toward advanced neuromodulation therapies.

Global Neuromodulation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global neuromodulation devices market report on the basis of product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulation
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Parkinson's Disease
  • Chronic Pain
  • Migraine
  • Epilepsy
  • Tremor
  • Depression
  • Urinary & Faecal Incontinence
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Ambulatory Surgery Centers (ASC)
  • Clinics & Physiotherapy Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68039-958-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neuromodulation Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Government funding for research and development
      • 3.2.1.2. Technological advancements in neuromodulation devices
      • 3.2.1.3. Increasing prevalence of neurological disorders
      • 3.2.1.4. Growing reimbursement coverage
      • 3.2.1.5. Expanding applications
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Increasing number of clinical trials and studies
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Product recalls
      • 3.2.4.2. Alternatives to neuromodulation systems
  • 3.3. Neuromodulation Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Neuromodulation Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Neuromodulation Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Neuromodulation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal cord stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep brain stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric electrical stimulation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neuromodulation Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Neuromodulation Devices Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Neuromodulation Devices Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Parkinson's Disease
    • 5.4.1. Parkinson's disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic pain market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Migraine
    • 5.6.1. Migraine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Epilepsy
    • 5.7.1. Epilepsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Tremor
    • 5.8.1. Tremor market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. Depression
    • 5.9.1. Depression market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Urinary & Fecal Incontinence
    • 5.10.1. Urinary & fecal incontinence market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neuromodulation Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Neuromodulation Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global Neuromodulation Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & physiotherapy centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neuromodulation Devices Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. Reimbursement scenario
      • 7.3.2.5. U.S. neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Reimbursement scenario
      • 7.3.3.5. Canada neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Reimbursement scenario
      • 7.3.4.5. Mexico neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Reimbursement scenario
      • 7.4.2.5. UK neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Reimbursement scenario
      • 7.4.3.5. Germany neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Reimbursement scenario
      • 7.4.4.5. France neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Reimbursement scenario
      • 7.4.5.5. Italy neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Reimbursement scenario
      • 7.4.6.5. Spain neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Reimbursement scenario
      • 7.4.7.5. Sweden neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Reimbursement scenario
      • 7.4.8.5. Denmark neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Reimbursement scenario
      • 7.4.9.5. Norway neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. China neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Japan neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. India neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Reimbursement scenario
      • 7.5.5.5. South Korea neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. Australia neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Thailand neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Brazil neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Argentina neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East and Africa
    • 7.7.1. Middle East and Africa neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. South Africa neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Saudi Arabia neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. UAE neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Kuwait neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Abbott (St. Jude Medical)
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Medtronic
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Aleva Neurotherapeutics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Nexstim
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. LivaNova PLC
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Neuropace Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Mainstay Medical
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Saluda Medical Pty Ltd
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Biotronik
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. electroCore, Inc.
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. MicroTransponder Inc.
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. tVNS Technologies GmbH
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. Laborie
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-958-9

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America neuromodulation devices market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 4 North America neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 7 U.S. neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 10 Canada neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 13 Mexico neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe neuromodulation devices market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 17 Europe neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Germany neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 20 Germany neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 22 UK neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 23 UK neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 25 France neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 26 France neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 27 France neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 29 Italy neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 32 Spain neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Denmark neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 35 Denmark neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Sweden neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 38 Sweden neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Norway neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 41 Norway neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific neuromodulation devices market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 47 China neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 48 China neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 49 China neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Japan neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 51 Japan neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 53 India neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 54 India neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 55 India neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 57 South Korea neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 58 South Korea neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Australia neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 60 Australia neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 63 Thailand neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 64 Thailand neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 65 Latin America neuromodulation devices market, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 67 Latin America neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 68 Latin America neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Brazil neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 70 Brazil neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 71 Brazil neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 72 Argentina neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 73 Argentina neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 74 Argentina neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 75 MEA neuromodulation devices market, by region, 2021 - 2033 (USD Million)
  • Table 76 MEA neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 77 MEA neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 78 MEA neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 79 South Africa neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 80 South Africa neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Africa neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 85 UAE neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 86 UAE neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 87 UAE neuromodulation devices market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Kuwait neuromodulation devices market, by product type, 2021 - 2033 (USD Million)
  • Table 89 Kuwait neuromodulation devices market, by application, 2021 - 2033 (USD Million)
  • Table 90 Kuwait neuromodulation devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neuromodulation devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Neuromodulation devices - market size and growth prospects (USD Million)
  • Fig. 11 Neuromodulation devices market: Industry Value Chain Analysis
  • Fig. 12 Neuromodulation devices market: Market Dynamics
  • Fig. 13 Neuromodulation devices market: PORTER's Analysis
  • Fig. 14 Neuromodulation devices market: PESTEL Analysis
  • Fig. 15 Neuromodulation devices market share by product type, 2025 & 2033 (USD Million)
  • Fig. 16 Neuromodulation devices market, by product type: market share, 2023 & 2030
  • Fig. 17 Spinal cord stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Deep brain stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Sacral nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Vagus nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Gastric electrical stimulation market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Neuromodulation devices market share by application, 2025 & 2033 (USD Million)
  • Fig. 24 Neuromodulation devices market, by application: market share, 2025 & 2033
  • Fig. 25 Parkinson's disease market share by application, 2025 & 2033 (USD Million)
  • Fig. 26 Chronic Pain market share by application, 2025 & 2033 (USD Million)
  • Fig. 27 Migraine market share by application, 2025 & 2033 (USD Million)
  • Fig. 28 Epilepsy market share by application, 2025 & 2033 (USD Million)
  • Fig. 29 Tremor market share by application, 2025 & 2033 (USD Million)
  • Fig. 30 Depression market share by application, 2025 & 2033 (USD Million)
  • Fig. 31 Urinary & fecal incontinence market share by application, 2025 & 2033 (USD Million)
  • Fig. 32 Others market share by application, 2025 & 2033 (USD Million)
  • Fig. 33 Neuromodulation devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 34 Neuromodulation devices market, by end use: market share, 2023 & 2030
  • Fig. 35 Hospitals & Ambulatory Surgery Centers (ASC) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Clinics & physiotherapy centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 Regional marketplace: key takeaways
  • Fig. 39 North America neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 US neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Germany neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 France neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Italy neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Spain neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Norway neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific neuromodulation devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 China neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 MEA neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Saudi Arabia neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 UAE neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Kuwait neuromodulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key company categorization
  • Fig. 68 Company market positioning
  • Fig. 69 Key company market share analysis, 2025
  • Fig. 70 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!